share_log

PharmaCyte Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(37.0%)

SEC announcement ·  Nov 22, 2023 16:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more